Programme

Please note that this programme will continue to be updated as and when sessions and speakers are confirmed.

07:30
Registration & Refreshments
Session 1: Meet the Professor
08:00
Histopathological/radiological correlation of pulmonary mycosis
Professor Kazutoshi Shibuya - View Bio
09:00
Introduction and Summary of Global Disease Burden
David W. Denning - View Bio
Session 2: Understanding antifungal activity in Aspergillus
Chair: Nir Osherov & Anna Prigitano
09:20
Inhibition of pyrimidine biosynthesis and salvage
Fabio Gsaller - View Bio
09:45
Aspergillus fumigatus Bud4 and Rho4 proteins are essential for echinocandin resistance and for fungal virulence.
Xabier Guruceaga - View Bio
10:00
Conserved Regulators of the Septation Initiation Network are required for Aspergillus fumigatus Echinocandin Resistance and Virulence
Mr Harrison Thorn
10:15
Exploring Novel Glycoconjugates as Promising Antifungal Agents Targeting Azole-Resistant Rhizopus delemar and Aspergillus fumigatus
Dr Pooja Vijayaraghavan
10:30
A role for pulmonary fibroblasts in antifungal defense
David Askew - View Bio
10:45
Q&A
10:55
Coffee Break and Poster Viewing
Session 3: New diagnostics for aspergillosis, or old diagnostics in new clothes?
Chair: Felix Bongomin & Elena De Carolis
11:25
PoC tests for antigen and antibody – are they really point of care?
Robina Aerts - View Bio
11:50
Rapid and Reliable Detection of Mucormycosis Using Colorimetric Loop-Mediated Isothermal Amplification (LAMP)
Professor Ashraf Ibrahim - View Bio
12:05
mNGS combined with qPCR for rapid identification of pathogen in non-invasive fungal sinusitis
PhD Xiao Liu - View Bio
12:20
Evaluation of LDBio Aspergillus ICT lateral flow assay for the diagnosis of allergic bronchopulmonary aspergillosis in adult asthmatics
Dr Inderpaul Sehgal - View Bio
12:35
Does identification of cryptic Aspergilli actually matter?
Nathan Wiederhold - View Bio
13:00
Lunch and Poster Viewing
Session 4: Antifungals in the critically ill
Chair: Sarah Hammond & Katrien Lagrou
14:30
Optimal antifungal strategies to prevent mould infections deaths in solid organ transplant recipients
Maricela Valerio Minero - View Bio
14:55
Polymeric nanoparticles for the delivery of antifungal drugs into pathogenic fungi
Dr Thomas Orasch - View Bio
15:10
In vivo antifungal screening against triazole-resistant and -susceptible Aspergillus fumigatus using bioluminescence imaging in Galleria mellonella
Ms Eliane Vanhoffelen - View Bio
15:25
Optimal antifungal strategies to prevent mould infections deaths in ICU patients
Daniele Giacobbe - View Bio
15:50
Coffee Break
Session 5: Understanding how Aspergillus causes disease
Chair: Koichiro Asano & Arianna Tavanti
16:30
Engineering neutrophils to combat fungal disease
Anna Huttenlocher - View Bio
16:55
The Aspergillus fumigatus morphogenetic NDR kinase, CotA, partially exerts carbon preference through the translational repressor, ssdA
Dr Adela Martin-Vicente - View Bio
17:10
The two polymers behind one false identity, a new perspective on galactosaminogalactan and Aspergillus fumigatus biofilm formation.
François Le Mauff - View Bio
17:25
Contrast of eosinophil or neutrophil taps for Aspergillus
Josiane Sabbadini-Neves - View Bio
17:50
Welcome Reception
Session 6: Breakfast session
Chair: David Denning
08:00
The Impact of Collaboration
IMMY - JT Harrison
08:10
TFF VORI in invasive pulmonary aspergillosis.
Dr Zamaneh Mikhak - TFF Pharmaceuticals
08:20
Fosmanogepix – A First-in-Class Broad Spectrum Agent for the Treatment of Invasive Yeast and Mold Infections
Dr Mark Jones - Basilea - View Bio
08:30
Update on SF001: Elion’s new polyene antifungal
Kieren Marr - Elion Therapeutics
08:40
Progress of Olorofim clinical development
Daniela Zinzi - F2G
08:50
PUR1900 in Allergic Bronchopulmonary Aspergillosis India Phase 2 Study Protocol
Sandesh Sawant - Cipla
Session 7: Airways and Disease
Chair: Vishu Aimanianda & Prof. Eva Van Braeckel
09:10
Surfactant protein-D: a breath of fresh air in the battle against Aspergillus
Sarah Delliere - View Bio
09:35
Combination of the mutations in hmg1 and in cyp51A results in high-level triazole-resistance in Aspergillus fumigatus causing chronic cavitary pulmonary aspergillosis
Dr Wei Liu - View Bio
09:50
Mucormycosis in Rural Central Valley California
Dr Almira Opardija - View Bio
10:05
Machine Learning Prediction of Chronic Pulmonary Aspergillosis in Resource Constraint Settings using Radiological and Laboratory Features
Mr Oluwaseyi Jessy Balogun - View Bio
10:20
Updated definition of ABPA and assessment of therapeutic response
Ritesh Agarwal - View Bio
10:45
Coffee Break and Poster Viewing
Session 8: Top 6 Papers in mucormycosis and aspergillosis
Chair: Jean-Pierre Gangneux
11:15
Top 6 Papers in mucormycosis and aspergillosis
Nir Osherov and Felix Bongomin
Session 9: Vaccine opportunities?
Chair: Arunaloke Chakrabarti & Guiliana Lo Cascio
12:15
A vaccine for aspergillosis - just a pipe dream?
Karen Norris - View Bio
12:35
Single nucleotide polymorphism rs4644 in LGALS3 affects antifungal immunity and predisposes to influenza-associated pulmonary aspergillosis
Mr Simon Feys - View Bio
12:50
Opportunities and challenges in development of a vaccine to prevent mucormycosis
Amanda Santos - View Bio
13:15
Lunch and Poster Viewing
14:30
“Meet the expert” collaboration
David Denning and Jean-Pierre Gangneux
17:00
End of Day 2
Session 10: Meet the Professor
08:00
How genomics contributes to understanding pathogenicity
Oliver Kurzai - View Bio
Session 11: Quick fire summaries of Fumigatus mycotoxins
Chair: David Denning & Anna Huttenlocher
09:00
Ergot alkaloids
Daniel Panaccione - View Bio
09:10
Gliotoxin
Daniel Scharf - View Bio
09:20
Fumagillin
Xabier Guruceaga - View Bio
09:30
Sphingofungins
Jens Christian Frisvad - View Bio
09:40
Helicopter view of inhaled mycotoxins and human illness from indoor exposure
Irene Grant - View Bio
09:50
Group discussion on mycotoxins
10:20
Coffee Break
Session 12: New antifungals
Chair: Martin Hoenigl & Livio Pagano
10:50
Novel approaches for Treatment of Aspergillosis and Mucormycosis
Rosanne Sprute - View Bio
11:25
Pioneering preclinical models to study mixed triazole-susceptible and triazole-resistant Aspergillus fumigatus infections
Dr Agustin Resendiz Sharpe - View Bio
11:45
Spatial analysis to evaluate enviromental factors related to Aspergillus Fumigatus Azole resistance in the Netherlands
Dr Massimo Cogliati - View Bio
12:05
Eosinophils or IgE in ABPA – which determines response to biologics?
Koichiro Asano - View Bio
12:30
Lunch and Poster Session #2
Session 13: Mucormycosis and aspergillosis impact
Chair: Robina Aerts & Muhammad Irfan
14:10
Social determinants of health driving risk for aspergillosis and mucormycosis
Jeff Jenks - View Bio
14:35
Aspergillus spp. / Mucorales duplex PCR assay inputs for the diagnosis of Aspergillus / Mucorales coinfections
Dr Sebastien Imbert - View Bio
15:00
Discovery of a novel second mechanism of action of the triazole antifungals against Aspergillus fumigatus
Dr Jeffrey Rybak - View Bio
15:15
Visualizing the dynamic cellular host response in a precision-cut lung slice model of influenza-associated pulmonary aspergillosis with confocal microscopy
Lauren Michiels - View Bio
15:30
Is chronic pulmonary aspergillosis a minor chest problem or can it be lethal?
Muhammad Irfan - View Bio
15:55
Coffee Break
Session 14: Foreseeing the future for airborne mould acquisition and disease
Chair: Maurizio Sanguinetti and Esther Segal
16:20
Induced immunological defects in virus-associated IPA
Joost Wauters - View Bio
16:45
Fighting Aspergillus infection using biocontrol bacteria: A proof of concept study for environmental interference in a translational setting
Dr Fabio Palmieri - View Bio
17:00
Environmental and bioclimatic factors influencing fungal distribution along European shores and health impacts
Massimo Cogliati - View Bio
17:25
Host factors and Aspergillus metabolites in time: implications for invasive aspergillosis development and diagnostics
Professor Vladimir Havlicek - View Bio
17:40
Natural disasters as a driver of mould infections
Danila Seidel - View Bio
18:05
Round table: Towards a consensus for guiding monitoring environmental fungal exposure and prevention strategies
Jean-Pierre Gangneux - View Bio
18:20
Closing remarks and award of poster prizes
Jean-Pierre Gangneux and Esther Segal
18:35
Snacks and AAAM2026 Discussion